User profiles for I. V. Ozerov

Ivan V. Ozerov

Insilico Medicine
Verified email at insilicomedicine.com
Cited by 1871

[HTML][HTML] AI-powered therapeutic target discovery

FW Pun, IV Ozerov, A Zhavoronkov - Trends in Pharmacological Sciences, 2023 - cell.com
Disease modeling and target identification are the most crucial initial steps in drug discovery,
and influence the probability of success at every step of drug development. Traditional …

[HTML][HTML] Vive la radiorésistance!: converging research in radiobiology and biogerontology to enhance human radioresistance for deep space exploration and …

…, XW Mao, MJ Pecaut, D Kaminskiy, IV Ozerov… - Oncotarget, 2018 - ncbi.nlm.nih.gov
While many efforts have been made to pave the way toward human space colonization, little
consideration has been given to the methods of protecting spacefarers against harsh …

[HTML][HTML] Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy

…, V Pham, R Bedi, A Zhavoronkov, IV Ozerov… - Nature …, 2018 - nature.com
A majority of cancers fail to respond to immunotherapy with antibodies targeting immune
checkpoints, such as cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed death-1 (PD-1)…

[HTML][HTML] AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

…, Y Liu, V Naumov, A Shneyderman, IV Ozerov… - Chemical …, 2023 - pubs.rsc.org
The application of artificial intelligence (AI) has been considered a revolutionary change in
drug discovery and development. In 2020, the AlphaFold computer program predicted protein …

[HTML][HTML] Machine learning on human muscle transcriptomic data for biomarker discovery and tissue-specific drug target identification

P Mamoshina, M Volosnikova, IV Ozerov, E Putin… - Frontiers in …, 2018 - frontiersin.org
Ozerov Ivan V. Ozerov 1 Evgeny Putin, Evgeny Putin 1,3 Ekaterina Skibina Ekaterina
Skibina 1 Franco Cortese Franco Cortese 4 Alex Zhavoronkov,, Alex Zhavoronkov 1,4,5 …

[HTML][HTML] A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models

…, J Chen, H Zhao, S Rao, C Kuppe, IV Ozerov… - Nature …, 2024 - nature.com
… out a phase 0 single-micro-dose study in healthy participants (ACTRN12621001541897)
to evaluate INS018_055 pharmacokinetics (PK), in which we observed that an intravenous

[HTML][HTML] In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development

IV Ozerov, KV Lezhnina, E Izumchenko… - Nature …, 2016 - nature.com
Signalling pathway activation analysis is a powerful approach for extracting biologically relevant
features from large-scale transcriptomic and proteomic data. However, modern pathway-…

[HTML][HTML] Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine

…, HW Leung, BHM Liu, X Long, IV Ozerov… - Aging (Albany …, 2022 - ncbi.nlm.nih.gov
Aging biology is a promising and burgeoning research area that can yield dual-purpose
pathways and protein targets that may impact multiple diseases, while retarding or possibly …

[HTML][HTML] Identification of therapeutic targets for amyotrophic lateral sclerosis using PandaOmics–an AI-enabled biological target discovery platform

…, J Gao, A Shneyderman, IV Ozerov… - Frontiers in Aging …, 2022 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease with ill-defined
pathogenesis, calling for urgent developments of new therapeutic regimens. Herein, we …

[HTML][HTML] Precious1GPT: multimodal transformer-based transfer learning for aging clock development and feature importance analysis for aging and age-related …

…, GHD Leung, HW Leung, FW Pun, IV Ozerov… - Aging (Albany …, 2023 - ncbi.nlm.nih.gov
Aging is a complex and multifactorial process that increases the risk of various age-related
diseases and there are many aging clocks that can accurately predict chronological age, …